EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Response to High‐Dose Topical Capsaicin in Neuropathic Pain: Absence of Deep Pain as a Predictor of Analgesic Effect

Manon Sendel iD, Lena Ehmke, Andreas Dunst, Jan Vollert, Henrike Bruckmüller, Sandra Brügge, Stefanie Rehm, Janne Gierthmühlen, Dilara Kersebaum, Ingolf Cascorbi, Ralf Baron, Julia Forstenpointner

European Journal of Pain · 2026-01 · 30 (1)

DOI: 10.1002/ejp.70200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pain, online erschienen am 09.01.2026. Verfasst von Manon Sendel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany. Hauptthemen laut MEDLINE: Neuralgia, Capsaicin, Sensory System Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Topical high‐dose capsaicin treatment is a recommended therapy for localised neuropathic pain with good tolerability and no identified drug interactions. However, it is not effective for every patient. So far, few parameters in patient history have been identified as predictors for response to capsaicin treatment. The aim of this prospective non‐interventional exploratory study was to improve prediction of treatment response to high‐dose capsaicin by including quantifiable parameters and standardised questionnaires.

Methods

Forty‐eight patients with peripheral neuropathic pain were included in the study. In addition to questionnaires assessing pain and patient‐reported outcome measures, the function of transient receptor potential vanilloid 1 (TRPV1) receptors in the affected skin was assessed via functional laser‐speckle‐contrast‐analysis (fLASCA) and sensory testing was performed. Furthermore, the effects of genetic variants in TRPV1 and endothelial NO‐synthase (eNOS) were tested by genotyping for TRPV1 rs8065080 (c.1911A>G, p.I585V), TRPV1 rs222747 (c.1103C>G, p.M315I) and eNOS rs1799983 (c.894 T>G, p.D298E).

Results

Patient‐reported catastrophizing was identified as the most important response predictor. Higher vibration detection threshold and higher pressure pain threshold showed the highest prediction values of sensory parameters. Combined, these three parameters predicted over a quarter of the level of pain relief. The genetic variant for TRPV1 rs222747 showed a significant impact on pain relief with a pain relief prediction of 13% or more.

Conclusion

A higher pressure pain threshold, a higher vibration detection threshold, higher pain catastrophizing and the presence of the TRPV1 variant rs222747 are associated with more pain relief from high‐dose capsaicin treatment and provide promising targets for future investigation. Significance Statement This exploratory study identifies promising predictors for analgesic response to high‐concentration capsaicin. The models generated in this study include a spectrum of different variables considering psychological factors as well as functional nerve‐fibre assessments and genetic polymorphisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaCapsaicinSensory System AgentsHumansFemaleMaleTRPV Cation ChannelsMiddle AgedProspective StudiesPain MeasurementAgedTreatment OutcomeAdultNitric Oxide Synthase Type IIIAdministration, Topical

Substanzen

CapsaicinTRPV Cation ChannelsTRPV1 protein, humanNitric Oxide Synthase Type IIISensory System AgentsNOS3 protein, human

Autor:innen und Institutionen

  • Division of Neurological Pain Research and Therapy, Department of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter, Exeter, UK.
  • Institute for Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Department of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway.
  • Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Kiel, Germany.

ORCID-Profile: Manon Sendel

Zitieren

APA

Sendel, M., Ehmke, L., Dunst, A., Vollert, J., Bruckmüller, H., Brügge, S., Rehm, S., Gierthmühlen, J., Kersebaum, D., Cascorbi, I., Baron, R., & Forstenpointner, J. (2026). Response to High‐Dose Topical Capsaicin in Neuropathic Pain: Absence of Deep Pain as a Predictor of Analgesic Effect. European Journal of Pain, 30(1). https://doi.org/10.1002/ejp.70200

Vancouver

Sendel M, Ehmke L, Dunst A, Vollert J, Bruckmüller H, Brügge S, et al. Response to High‐Dose Topical Capsaicin in Neuropathic Pain: Absence of Deep Pain as a Predictor of Analgesic Effect. European Journal of Pain. 2026;30(1). doi:10.1002/ejp.70200

BibTeX
@article{Sendel2026,
  author = {Sendel, Manon and Ehmke, Lena and Dunst, Andreas and Vollert, Jan and Bruckmüller, Henrike and Brügge, Sandra and Rehm, Stefanie and Gierthmühlen, Janne and Kersebaum, Dilara and Cascorbi, Ingolf and Baron, Ralf and Forstenpointner, Julia},
  title = {Response to High‐Dose Topical Capsaicin in Neuropathic Pain: Absence of Deep Pain as a Predictor of Analgesic Effect},
  journal = {European Journal of Pain},
  year = {2026},
  volume = {30},
  number = {1},
  doi = {10.1002/ejp.70200}
}
Kostenlos starten →